MME (psychedelic)

MME
Names
	Preferred IUPAC name 1-(5-Ethoxy-2,4-dimethoxyphenyl)propan-2-amine
	Other names 2,4-Dimethoxy-5-ethoxyamphetamine
Identifiers
CAS Number	23693-32-5 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL3244455;
ChemSpider	21106338 ;
PubChem CID	44719602;
UNII	9KL74SEV4U;
CompTox Dashboard (EPA)	DTXSID90660374;
	InChI InChI=1S/C13H21NO3/c1-5-17-13-7-10(6-9(2)14)11(15-3)8-12(13)16-4/h7-9H,5-6,14H2,1-4H3 Key: NAMNXRTWJMASNT-UHFFFAOYSA-N ; InChI=1/C13H21NO3/c1-5-17-13-7-10(6-9(2)14)11(15-3)8-12(13)16-4/h7-9H,5-6,14H2,1-4H3 Key: NAMNXRTWJMASNT-UHFFFAOYAR;
	SMILES COc1cc(OC)c(cc1OCC)CC(C)N;
Properties
Chemical formula	C13H21NO3
Molar mass	239.315 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

MME, or 2,4-dimethoxy-5-ethoxyamphetamine, is a lesser-known psychedelic drug. It is a dimethoxy-ethoxy analog of TMA-2. MME was first synthesized by Alexander Shulgin from ethylvanillin. In his book PiHKAL, the minimum dosage is listed as 40 mg and above, and the duration listed as 6–10 hours. Shulgin gives MME a ++ on the Shulgin Rating Scale.